Characterization of compound missense mutation and deletion of carnitine palmitoyltransferase II in a patient with adenovirus-associated encephalopathy.
about
Abbreviated half-lives and impaired fuel utilization in carnitine palmitoyltransferase II variant fibroblastsClinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency.Diisopropylamine dichloroacetate, a novel pyruvate dehydrogenase kinase 4 inhibitor, as a potential therapeutic agent for metabolic disorders and multiorgan failure in severe influenzaHeat stroke with bimodal rhabdomyolysis: a case report and review of the literatureMitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis.
P2860
Characterization of compound missense mutation and deletion of carnitine palmitoyltransferase II in a patient with adenovirus-associated encephalopathy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Characterization of compound m ...... rus-associated encephalopathy.
@en
Characterization of compound m ...... rus-associated encephalopathy.
@nl
type
label
Characterization of compound m ...... rus-associated encephalopathy.
@en
Characterization of compound m ...... rus-associated encephalopathy.
@nl
prefLabel
Characterization of compound m ...... rus-associated encephalopathy.
@en
Characterization of compound m ...... rus-associated encephalopathy.
@nl
P2093
P356
P1476
Characterization of compound m ...... rus-associated encephalopathy.
@en
P2093
Dengbing Yao
Hiroshi Kido
Junji Chida
Miyoko Yamaguchi
P304
P356
10.2152/JMI.58.210
P577
2011-08-01T00:00:00Z